No abstract available
Keywords:
Blood glucose; Diabetes duration; Sitagliptin; β-cell function.
MeSH terms
-
Blood Glucose / drug effects*
-
Blood Glucose / metabolism
-
Diabetes Mellitus, Type 2 / blood*
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Dipeptidyl-Peptidase IV Inhibitors / pharmacology
-
Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
-
Female
-
Glycated Hemoglobin / metabolism
-
Humans
-
Male
-
Middle Aged
-
Risk Reduction Behavior
-
Sitagliptin Phosphate / pharmacology
-
Sitagliptin Phosphate / therapeutic use*
-
Treatment Outcome
Substances
-
Blood Glucose
-
Dipeptidyl-Peptidase IV Inhibitors
-
Glycated Hemoglobin A
-
hemoglobin A1c protein, human
-
Sitagliptin Phosphate